期刊文献+

非小细胞肺癌组织Bmi-1表达与上皮间质转化关系 被引量:2

RELATIONSHIP BETWEEN Bmi-1 EXPRESSION AND EPITHELIAL-MESENCHYMAL TRANSITION IN NON-SMALL-CELL LUNG CANCER
下载PDF
导出
摘要 目的检测B细胞特异性莫洛鼠白血病病毒插入位点-1(Bmi-1)在非小细胞肺癌(NSCLC)组织的表达,探讨其与上皮间质转化(EMT)的关系。方法采用免疫组化PV-9000两步法检测50例NSCLC组织及30例癌旁相对正常组织Bmi-1、E-钙黏素(E-cadherin)和波形蛋白(Vimentin)的表达情况。结果 Bmi-1、E-cadherin和Vimentin蛋白在NSCLC和癌旁相对正常组织间的表达强度差异均有显著性(Z=-4.413~-2.965,P<0.05)。肺癌组织Bmi-1蛋白与E-cadherin的表达呈负相关(r=-0.416,P<0.05),与Vimentin的表达呈正相关(r=0.356,P<0.05)。结论在NSCLC中,Bmi-1蛋白的过表达伴随着E-cadherin的表达下调和Vimentin的表达上调。Bmi-1可能与NSCLC发生EMT有关,并在其侵袭转移的过程中发挥重要作用。 Objective To detect the expression of B-cell specific Moloney murine leukemia virus insertion site 1(Bmi-1) and investigate its association with epithelial-mesenchymal transition(EMT) in non-small-cell lung cancer(NSCLC). Methods Using PV-9000 immunohistochemical method,the expressions of Bmi-1,E-cadherin and Vimentin in 50 NSCLC samples and 30 correspondingly normal paraneoplastic tissues. Results There were significant differences in the expressions of Bmi-1,E-cadherin and Vimentin between NSCLC and the paraneoplastic normal tissues(Z=-4.413——2.965,P〈0.05).In the cancer tissue,the expression of Bmi-1 was negatively correlated with E-cadherin(r=-0.416,P〈0.05),and positively with Vimentin(r=0.356,P〈0.05). Conclusion In NSCLC,the over expression of Bmi-1 is accompanied by down-regulation expression of E-cadherin and up-regulation expression of Vimentin.Bmi-1 is probably related to EMT in NSCLC and plays a crucial role in the process of invasion and metastasis of this condition.
出处 《齐鲁医学杂志》 2012年第2期101-103,106,共4页 Medical Journal of Qilu
关键词 非小细胞肺 上皮间质转化 BMI-1 免疫组织化学 carcinoma non-small-cell lung epithelial-mesenchymal transition Bmi-1 immunohistochemistry
  • 相关文献

参考文献8

  • 1HAO W L,WANG D Y,HE J X.The role of gene expres-sion profiling in early-stage non-small cell lung cancer[J].JThorac Dis,2000,2(2):89-99.
  • 2THIERY J P.The epithelial mesenehymal transitions indeve-lopment and pathologies[J].Current Opinion in Cell Biol-ogy,2003,15(6):740-746.
  • 3LOHUIZENM,FRASCHM,WIENTJENS E,et al.Se-quence similarity between the mammalian bmi-1proto-onco-gene and the drosophila regulatory genes Psc and Su(z)2[J].Nature,1991,353(6342):353-355.
  • 4SONG L B,LI J,LIAO W T,et al.The polycomb group pro-tein Bmi-1represses the tumor suppressor PTEN and inducesepithelial-mesenchymal transition in human nasopharyngealepithelial cells[J].J Clin Invest.2009,119(12):3626-3636.
  • 5杨雅莹,李艳青,易永芬,何婷婷,肖钟.高尔基体α-甘露糖苷酶Ⅱ在胃癌中的表达及其与E-cadherin、Galectin-3的关系[J].重庆医科大学学报,2010,35(9):1313-1317. 被引量:9
  • 6ALKEMA M J,WIEGANT J,RAAP A K,et al.Char-acte-rization and chromosomal localization of the human proto-oncogene BMI-1[J].Hum Mol Genet,1993,2(10):1597-1603.
  • 7冯艳,宋立兵,郭宝红,廖雯婷,李满枝,刘万里,曾木圣,张玲.Bmi-1在乳腺癌组织中的表达及意义[J].癌症,2007,26(2):154-157. 被引量:67
  • 8项锋钢,党受琴,冉雯雯,李宏.非小细胞肺癌组织Bmi-1与C-myc蛋白表达及其相关性[J].青岛大学医学院学报,2011,47(3):204-206. 被引量:10

二级参考文献29

  • 1Qing Wang~1 Zhi Ying Lin~2 Xiao Li Feng~3 ~1Department of Microbiology,Medical Center of Fudan University.the former Shanghai Medical University,Shanghai 200032,China ~2Liver Cancer Institute,Zhongshan Hospital,Shanghai 200032,China ~3Shanghai Institute of Biochemistry,Academy Sinica,Shanghai 200031,ChinaQing Wang earned master degree from Shanghai Medical University in 1996,now a senior lecturer of microbiology,specialized in the role of oncogcncs on tumor metastasis,having 8 papers published..Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection[J].World Journal of Gastroenterology,2001,7(3):335-339. 被引量:48
  • 2陈双玲,时岩,靳玉兰,刘音,赵方萄,朱立平.6A8α-甘露糖苷酶表达减弱和表达正常鼻咽癌细胞间的差异基因表达[J].中国医学科学院学报,2005,27(3):305-310. 被引量:8
  • 3冯艳,宋立兵,郭宝红,廖雯婷,李满枝,刘万里,曾木圣,张玲.Bmi-1在乳腺癌组织中的表达及意义[J].癌症,2007,26(2):154-157. 被引量:67
  • 4Elsen J M H V D,Kuntz D A,Rose D R,et al.Stmcture of GM Ⅱ:a target for inhibition of growth and metastasis of cancer cells[J].EMBO,2001,20(12):3008-3017.
  • 5Shah N,Kuntz D A,Rese D R,et al.Golgi alpha-mannosidase Ⅱ cleaves two sugars sequentially in the same catalytic site[J].Proc Nail Acad Sci U S A,2008,105(28):9570-9575.
  • 6Kuntz D A,Tarling C A,Withers S G,et al.Structural analysis of Golgi alpha-mannos-idase Ⅱ inhibitors identified from a focused glycosidase inhibitor screen[J].Biochemistry,2008,47 (38):10058-10068.
  • 7Kuntz D A,Zhong W,C,uo J,et al.The molecular basis of inhibition of Golgi alpha-mannosidase Ⅱ by mannostatin A[J].Chembiochem,2009,10(2):268-277.
  • 8Crispin M,Chang V T,Harvey D J,et al.A human embryonic kidney 293T cell line mutated at the Golgi alpha-mannosidase Ⅱ locus[J].J Biol Chem,2009,284(32):21684-21695.
  • 9Sun J Y,Yang H,Miao S,et al.Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo[J].Phytomedicine,2009,16(11):1070-1074.
  • 10Hamaguchi J,Nakagawa H,Takahashi M,et al.Swainsenine reduces 5-fluorouracil tolerance in the multistage resistance of coloroctal cancer cell lines[J].Mol Cancer,2007,6:58.

共引文献81

同被引文献41

  • 1Yadirgi G, Leinster V, Acquati S, et al. Conditional activation of Bmi-l expression regulates self-renewal, apoptosis, and differentiation of neural stem/progenitor cells in vitro and in vivo[J].Stem Cells.2011, 29(4):700-712.
  • 2Cohen KJ, Hanna JS, Prescott JE, et al. Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity[J]. Mol Cell Biol, 1996, 16(10): 5527-5535.
  • 3Xin T, Zhang FB, Sui GJ, et al. Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity[J]. Br J Biomed Sci, 2012, 69(2): 62-66.
  • 4Alkema MJ, Wiegant J, Raap AK, et al. Characterization and chromosomal localization of the human proto-oncogene Bmi-1[J].Hum Mol Genet.1993, 2(10):1597-1603.
  • 5Lee K, Adhikary G, Balasubramanian S, et al. Expression of Bmi-1 in epidemis enhances cell survivalby altering cell cycle regulatory protein expression and inhibiting apoptosis[J].J Invest Dennatol.2008, 128(1):9-10.
  • 6Vonlanthen S, Heighway J, Altermatt HJ, et al. The Bmi-1 oncoprotein is differentially expressed in non small cell lung cancer and correlates with INK4A-ARF locus expression[J].Br J Cancer.2001, 84(10):1372-1376.
  • 7Hu J, Liu YL, Piao SL, et al. Expression patterns of USP22 and potential tmgets Bmi-1, trPEN, PAKT in non small cell lung cancer[J].Lung Cancer.2012, 77(3):593-599.
  • 8Tátrai P, Szepesi , Matula Z, et al. Combined introduction of Bmi-1 and hTERT immortalizes human adipose t1-derived stromal cells with low risk of transformation[J].Biochem Biophys Res Commun.2012, 422(1):28-35.
  • 9Silva J, García JM, Pea C, et al. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, hTERT, and c-myc expression in primary breast carcinomas[J].Clin Cancer Res.2006, 12(23):6929-6936.
  • 10Datta S, Hoenerhoff MJ, Bommi P, et al. Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways[J].Cancer Res.2007, 67(21):10286-10295.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部